RGS3
From Wikipedia, the free encyclopedia
Regulator of G-protein signalling 3
|
||||||||||||||
PDB rendering based on 2f5y. | ||||||||||||||
Available structures: 2f5y, 2oj4 | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | RGS3; C2PA; FLJ20370; FLJ31516; FLJ90496; PDZ-RGS3; RGP3 | |||||||||||||
External IDs | OMIM: 602189 MGI: 1354734 HomoloGene: 32440 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 5998 | 50780 | ||||||||||||
Ensembl | ENSG00000138835 | n/a | ||||||||||||
Uniprot | P49796 | n/a | ||||||||||||
Refseq | NM_017790 (mRNA) NP_060260 (protein) |
NM_001081650 (mRNA) NP_001075119 (protein) |
||||||||||||
Location | Chr 9: 115.26 - 115.4 Mb | n/a | ||||||||||||
Pubmed search | [1] | [2] |
Regulator of G-protein signalling 3, also known as RGS3, is a human gene.[1]
This gene encodes a member of the regulator of G-protein signaling (RGS) family. This protein is a GTP-ase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. Multiple alternatively spliced transcript variants have been described for this gene but the full-length nature of some transcripts is not yet known.[1]
[edit] References
[edit] Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298.
- Druey KM, Blumer KJ, Kang VH, Kehrl JH (1996). "Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family.". Nature 379 (6567): 742–6. doi: . PMID 8602223.
- Chatterjee TK, Eapen A, Kanis AB, Fisher RA (1998). "Genomic organization, 5'-flanking region, and chromosomal localization of the human RGS3 gene.". Genomics 45 (2): 429–33. doi: . PMID 9344672.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149.
- Dulin NO, Sorokin A, Reed E, et al. (1999). "RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Galpha11.". Mol. Cell. Biol. 19 (1): 714–23. PMID 9858594.
- Dulin NO, Pratt P, Tiruppathi C, et al. (2000). "Regulator of G protein signaling RGS3T is localized to the nucleus and induces apoptosis.". J. Biol. Chem. 275 (28): 21317–23. doi: . PMID 10749886.
- Linares JL, Wendling C, Tomasetto C, Rio MC (2000). "C2PA, a new protein expressed during mouse spermatogenesis.". FEBS Lett. 480 (2-3): 249–54. PMID 11034339.
- Shi CS, Lee SB, Sinnarajah S, et al. (2001). "Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation.". J. Biol. Chem. 276 (26): 24293–300. doi: . PMID 11294858.
- Lu Q, Sun EE, Klein RS, Flanagan JG (2001). "Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction.". Cell 105 (1): 69–79. PMID 11301003.
- Mittmann C, Schüler C, Chung CH, et al. (2001). "Evidence for a short form of RGS3 preferentially expressed in the human heart.". Naunyn Schmiedebergs Arch. Pharmacol. 363 (4): 456–63. PMID 11330340.
- Niu J, Scheschonka A, Druey KM, et al. (2002). "RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.". Biochem. J. 365 (Pt 3): 677–84. doi: . PMID 11985497.
- Kehrl JH, Srikumar D, Harrison K, et al. (2002). "Additional 5' exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3.". Genomics 79 (6): 860–8. doi: . PMID 12036301.
- Ikeda M, Okai M, Miyoshi T, et al. (2003). "Transcriptional suppression of the estrogen receptor by truncated estrogen receptor-alpha.". Horm. Metab. Res. 34 (8): 425–30. doi: . PMID 12198596.
- Hirabayashi S, Ohno H, Iida J, Hata Y (2003). "C2PA is a nuclear protein implicated in the heat shock response.". J. Cell. Biochem. 87 (1): 65–74. doi: . PMID 12210723.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). "DNA sequence and analysis of human chromosome 9.". Nature 429 (6990): 369–74. doi: . PMID 15164053.
- Tovey SC, Willars GB (2005). "Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.". Mol. Pharmacol. 66 (6): 1453–64. doi: . PMID 15383626.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi: . PMID 16189514.